Welcome : Guest

Neuralstem, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Neuralstem, Inc., which is principally involved in the Development and Commercialization of Regenerative Medicine Treatments. Illustrated with 22 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64975
Price: $1100
Company Type: Public
Pages: 23
Date: January 2016
Market Data Tables: 22

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Central Nervous System (CNS) Drugs......2
Table 1: Central Nervous System Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......2
Table 2: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......3
Table 3: Immune Globin Usage Market by Indication Worldwide (2014) - Percentage Share Breakdown by Value Sales for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Immune Thrombocytopenia (ITP), Primary Immune Deficiency (PID), Other Central Nervous System (CNS) and Others......4
Table 4: Formulations Sales by Category in India (2014) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastrointestinal, Pain Management, and Others......5
Multiple Sclerosis......6
Table 5: Multiple Sclerosis Disease Occurrence by Type Worldwide (2014) - Percentage Breakdown by Volume for Begin MS, Primary Progressive MS, Relapsing-Remiting MS, and Secondary Progressive MS......6
Table 6: Specialty Multiple Sclerosis Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......7
Spinal Cord Injury......8
Table 7: Inpatient Rehabilitation Facility (IRF) Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Brain Injury, Cardiac Conditions, Fracture of the Lower Extremity, Major Joint Replacement, Neurological Disorders, Orthopedic, Spinal Cord Injury, Stroke, and Others......8
Table 8: No. of Spinal Cord Injuries (SCI) by Cause Worldwide (2015) - Percentage Market Share Breakdown for Falls, Sports, Vehicular, Violence, and Other......9
Table 9: Spinal Cord Injury Market by Payer in the US (2015) - Percentage Share Breakdown by Value for Medicaid, Medicare, and Private Insurance......10
Anti-Ageing......11
Table 10: Market for Prestige Facial Skin Care Products by Variant Type Global (2014) - Percentage Market Share Breakdown by Value Sales for Acne, Anti-Aging, Cleansers, Face Masks, Lip, Moisturizers and Toners......11
Table 11: Anti-Ageing Products Market by Category in China (2015) - Percentage Share Breakdown by Value for Skin Brightening and Others......12
Stroke Drugs......13
Table 12: Stroke Drugs Market by Brand in China (2015) - Percentage Share Breakdown by Value for Aodejin, Oudimei, Shenjie, Xueshuanto and Others......13
Speciality Drugs......14
Table 13: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......14
Table 14: Prescription Therapeutic Market by Segment in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Antibacterials, Antidiateics, Antihypertensives, Lipid Regulators, Mental Health, CNS, Pain, Respiratory Agents, and Others......15
Table 15: Speciality Drug Sales by Therapeutic Category in the US (2014) - Percentage Market Share Breakdown by Value for Anticoagulants, Cancer, Growth Deficiency, Hepatitis C, HIV, Inflammatory Conditions, Multiple Sclerosis, Pulmonary Hypertension, Respiratory Conditions, Transplant and Others......16
Table 16: Speciality Pharmaceuticals Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......17
Central Nervous System (CNS) Drugs......18
Table 17: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......18
Table 18: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......19
Multiple Sclerosis......20
Table 19: Market Shares of Leading Multiple Sclerosis Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biogen Idec, Novartis AG, Sanofi S.A., and Others......20
Alzheimer Disease Therapeutics......21
Table 20: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......21
Table 21: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......22
Post-Traumatic Stress Disorder......23
Table 22: Market Shares of Leading Drugs for Post-Traumatic Stress Disorder (PTSD) Treatment in the US (2015) - Percentage Share Breakdown by Value for Citalopram, Clonazepam, Escitalopram, Quetiapine, Quetiapine, Sertraline, and Others......23